{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:12:42Z","timestamp":1767892362848,"version":"3.49.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Health"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54 NS065736"],"award-info":[{"award-number":["U54 NS065736"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10286-018-0556-5","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:10:05Z","timestamp":1535364605000},"page":"589-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic treatment dilemma: baroreflex failure or autoimmune autonomic ganglionopathy?"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-0233","authenticated-orcid":false,"given":"Maureen C.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-6801","authenticated-orcid":false,"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"556_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.HYP.0000077441.45309.08","volume":"42","author":"Y Sharabi","year":"2003","unstructured":"Sharabi Y, Dendi R, Holmes C, Goldstein DS (2003) Baroreflex failure as a late sequela of neck irradiation. Hypertension 42:110\u2013116","journal-title":"Hypertension"},{"key":"556_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/01.HYP.0000160355.93303.72","volume":"45","author":"K Heusser","year":"2005","unstructured":"Heusser K, Tank J, Luft FC, Jordan J (2005) Baroreflex failure. Hypertension 45:834\u2013839","journal-title":"Hypertension"},{"key":"556_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autneu.2008.11.001","volume":"146","author":"V Iodice","year":"2009","unstructured":"Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA (2009) Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 146:22\u201325","journal-title":"Auton Neurosci"},{"key":"556_CR4","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons CH, Schmidt P, Biaggioni I et al (2017) The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol 264:1567\u20131582","journal-title":"J Neurol"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/01.wnl.0000178980.83477.14","volume":"65","author":"CH Gibbons","year":"2005","unstructured":"Gibbons CH, Vernino SA, Kaufmann H, Freeman R (2005) l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology 65:1104\u20131106","journal-title":"Neurology"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-018-0556-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:00:53Z","timestamp":1589648453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-018-0556-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s10286-018-0556-5","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.C.F. and A.S.B. have no conflicts of interest to declare. C.A.S. has received a research grant from the Doris Duke Foundation. C.A.S. received grant support from the Office of Orphan Products Development, Food and Drug Administration, grant #FD-R-04778-01-A3. C.A.S. has received a speaker honorarium from Lundbeck Pharmaceuticals. C.A.S. received consulting honoraria from Lundbeck and Theravance Biopharma. C.A.S is a member of the board for the American Autonomic Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was approved by the Institutional Review Board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}